Results 1 to 10 of about 274,076 (393)

Neutropenia.

open access: yesActa Médica Portuguesa, 1998
The authors reviewed the subject of neutropenia in what concern its definition, pathophysiology, clinical features, diagnosis and principles of treatment.
F Leite, J Coutinho
doaj   +3 more sources

Mecapegfilgrastim prophylaxis for neutropenia in patients with non-myeloid malignancies: A Chinese nationwide real-world study [PDF]

open access: yesBMC Cancer
Background Mecapegfilgrastim has been previously validated for efficacy and safety in neutropenia prevention during clinical trials. This nationwide, real-world study (RWS) evaluates its role in protecting against moderate to severe chemotherapy-induced ...
Shukui Qin   +22 more
doaj   +2 more sources

Secondary Neutropenias. [PDF]

open access: yesBiomedicines
Neutrophils are a critical component of immunity, particularly against bacteria and other pathogens, but also in inflammation and tissue repair. As a consequence, individuals with neutropenia, defined by a reduction in absolute neutrophil counts, exhibit a strong propensity to severe infections that typically present with muted symptoms.
Ward AC.
europepmc   +3 more sources

Neutropenia induced by high-dose intravenous benzylpenicillin in treating neurosyphilis: Does it really matter? [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2017
BACKGROUND:Prompt therapy with high-dose intravenous benzylpenicillin for a prolonged period is critical for neurosyphilis patients to avoid irreversible sequelae.
Rui-Rui Peng   +10 more
doaj   +1 more source

Transient Neutropenia in Immunocompetent Infants with Respiratory Syncytial Virus Infection

open access: yesViruses, 2021
The incidence of neutropenia and the association between neutropenia and severity of respiratory symptoms among infants with respiratory syncytial virus (RSV) infections remain to be elucidated.
Tatsuya Korematsu, Hiroshi Koga
doaj   +1 more source

Incidence of and risk factors for severe neutropenia during treatment with the modified FOLFIRINOX therapy in patients with advanced pancreatic cancer

open access: yesScientific Reports, 2022
Although FOLFIRINOX (l-Leucovorin/5-FU/Irinotecan/Oxaliplatin) is established as one of the standard therapies for patients with metastatic pancreatic cancer, the modified FOLFIRINOX (mFOLFIRINOX) is often used in clinical practice to reduce the ...
Ai Irisawa   +5 more
doaj   +1 more source

How to Make the Right Diagnosis in Neutropenia

open access: yesClinical Hematology International, 2021
Isolated neutropenia without anemia or thrombocytopenia is a common clinical problem. The etiology of neutropenia may vary from transient bone marrow suppression, caused by self-limited viral illnesses, to previously undiagnosed congenital syndromes or ...
Elena E. Solomou   +2 more
doaj   +1 more source

Characteristics of fungemia in a peruvian referral center: 5-year retrospective analysis

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2020
Retrospective descriptive study carried out to determine the characteristics of fungemia in 285 cancer patients hospitalized from 2012 to 2016 at the Instituto Nacional de Enfermedades Neoplásicas (INEN).
Freddy Villanueva   +6 more
doaj   +1 more source

Bayesian data assimilation to support informed decision-making in individualized chemotherapy [PDF]

open access: yes, 2020
An essential component of therapeutic drug/biomarker monitoring (TDM) is to combine patient data with prior knowledge for model-based predictions of therapy outcomes.
de Wiljes, Jana   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy